BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25715904)

  • 1. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.
    Simpson HB; Kegeles LS; Hunter L; Mao X; Van Meter P; Xu X; Kimeldorf MB; Pearlstein SL; Slifstein M; Shungu DC
    Psychiatry Res; 2015 Apr; 232(1):65-70. PubMed ID: 25715904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
    Fan S; Cath DC; van den Heuvel OA; van der Werf YD; Schöls C; Veltman DJ; Pouwels PJW
    Psychoneuroendocrinology; 2017 Mar; 77():211-217. PubMed ID: 28104554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
    Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
    J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
    Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB
    Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
    Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
    Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal structure and its association with N-Acetylaspartate and glutamate in autism spectrum disorder and obsessive compulsive disorder.
    Naaijen J; Zwiers MP; Forde NJ; Williams SC; Durston S; Brandeis D; Glennon JC; The Tactics Consortium ; Franke B; Lythgoe DJ; Buitelaar JK
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):118-129. PubMed ID: 29169826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
    Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
    Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies.
    Naaijen J; Lythgoe DJ; Amiri H; Buitelaar JK; Glennon JC
    Neurosci Biobehav Rev; 2015 May; 52():74-88. PubMed ID: 25712432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
    Ortiz AE; Ortiz AG; Falcon C; Morer A; Plana MT; Bargalló N; Lázaro L
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder.
    Naaijen J; Zwiers MP; Amiri H; Williams SCR; Durston S; Oranje B; Brandeis D; Boecker-Schlier R; Ruf M; Wolf I; Banaschewski T; Glennon JC; Franke B; Buitelaar JK; Lythgoe DJ
    Neuropsychopharmacology; 2017 Nov; 42(12):2456-2465. PubMed ID: 27869141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
    Park SE; Choi NG; Jeong GW
    Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects.
    Bartha R; Stein MB; Williamson PC; Drost DJ; Neufeld RW; Carr TJ; Canaran G; Densmore M; Anderson G; Siddiqui AR
    Am J Psychiatry; 1998 Nov; 155(11):1584-91. PubMed ID: 9812122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using magnetic resonance spectroscopy: A controlled study.
    Kosová E; Pajuelo D; Greguš D; Brunovský M; Stopková P; Fajnerová I; Horáček J
    Psychiatry Res Neuroimaging; 2023 Oct; 335():111721. PubMed ID: 37832259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
    Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
    J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.
    Brennan BP; Tkachenko O; Schwab ZJ; Juelich RJ; Ryan EM; Athey AJ; Pope HG; Jenike MA; Baker JT; Killgore WD; Hudson JI; Jensen JE; Rauch SL
    Neuropsychopharmacology; 2015 Jul; 40(8):1866-76. PubMed ID: 25662837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.